Rosen Law Firm Announces Proposed Settlement of Roka Bioscience, Inc. Class Action for $3.275 million
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Roka Bioscience, Inc. -- ROKA
TRENTON, N.J., July 25, 2016 (GLOBE NEWSWIRE) -- The Rosen Law Firm, P.A. announces that the United States District Court for the District of New Jersey has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of Roka Bioscience, Inc. (NASDAQ:ROKA):
SUMMARY NOTICE OF: (1) PENDENCY AND PROPOSED SETTLEMENT OF CLASS ACTION AND (2) HEARING ON PROPOSED SETTLEMENT
TO: ALL PERSONS WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ROKA BIOSCIENCE, INC. (“ROKA”) DURING THE PERIOD FROM JULY 17, 2014 THROUGH MARCH 26, 2015, INCLUSIVE (THE “CLASS PERIOD”):
YOU ARE HEREBY NOTIFIED that the above-captioned action has been certified as a class action for settlement purposes and that the Lead Plaintiff has reached a proposed settlement with Roka to resolve all claims in the case for $3,275,000 in cash. The settlement Class consists of all persons and entities who purchased or otherwise acquired Roka securities pursuant or traceable to Roka’s Initial Public Offering Registration Statement, including those who purchased or otherwise acquired Roka common stock during the Class Period.
A hearing will be held on November 9, 2016, at 10:00 a.m., before United States District Judge Freda L. Wolfson, at the United States District Court for the District of New Jersey, located at 402 East State Street, Room 5E, Trenton, New Jersey 08608, to determine whether the Court should approve the proposed settlement as fair, reasonable, and adequate and whether the Court should grant Lead Counsel’s application for attorneys’ fees and expenses.
IF YOU ARE A CLASS MEMBER, YOUR RIGHTS WILL BE AFFECTED BY THIS SETTLEMENT, AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT MONEY.
If you have not yet received the full notice of the proposed settlement (the “Notice”), you may obtain it by contacting Roka Bioscience Securities Litigation, c/o Strategic Claims Services, 600 N. Jackson St., Ste. 3, P.O. Box 230, Media, PA 19063; telephone: 866-274-4004; email: email@example.com. You may also download the Notice from: www.strategicclaims.net.
To participate in the settlement, you must submit a Claim Form. You may download the Claim Form from www.strategicclaims.net, or you may contact the Claims Administrator to request a Claim Form and to be added to the mailing list. Completed Claim Forms must be postmarked or received by September 19, 2016, at the Claims Administrator’s address (printed above).
If you purchased or otherwise acquired Roka securities during the Class Period, you will be deemed a Class Member unless you ask to be excluded from the Class. Any requests for exclusion must be received by October 5, 2016, at the Claims Administrator’s address (printed above). Each request for exclusion must (i) state the name, address, telephone number, and e-mail address (if available) of the person or entity requesting exclusion, (ii) state that such person or entity requests exclusion from the Roka settlement, (iii) be signed by the person or entity requesting exclusion, and (iv) provide the date(s), price(s), and number(s) of shares of all purchases and sales of Roka securities during the Class Period, as well as account statements to verify all such transactions. You will be bound by any judgment rendered in the class action unless you timely request exclusion from the Class as explained in the Notice, even if you have pending or later file another lawsuit, arbitration, or other proceeding relating to the claims covered by this settlement. If you submit a valid and timely request for exclusion, you cannot share in the settlement money, cannot object to the settlement, and will not be bound by the settlement or the Court’s rulings.
The Notice also describes how you may object to the Settlement, the Plan of Allocation, the request for Attorneys’ Fees and Expenses, or Lead Plaintiff’s request for an award. All objections must be received by the Court (at the address printed above) and by the lawyers listed below no later than October 20, 2016:
Lead Counsel for the Class
Laurence Rosen, Esq.
Ralph C. Ferrara, Esq.
Inquiries, other than requests for copies of the Notice or for inclusion in the mailing list for future notices, may be directed to Lead Counsel for the Class.
Dated: June 28, 2016 BY ORDER OF THE COURT